115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Infigratinib versus gemcitabine plus cisplatin as first-line therapy in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: phase 3 PROOF trial
    Meeting Abstract

    Abou-Alfa, G.; Borbath, I.; Cohn, A.; Goyal, L.; Lamarca, A.; Macarulla, T.; Oh, D.; Roychowdhury, S.; Sadeghi, S.; Shroff, R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Maintenance olaparib in patients aged ≥65 years with a germline BRCA mutation and metastatic pancreatic cancer: Phase III POLO trial
    Meeting Abstract

    Kindler, H.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M.; Park, J.; Hochhauser, D.; Arnold, D.; Oh, D.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A first-in-human phase Ia/b, open-label, multicentre, dose-escalation study of BI 905711 in patients with advanced gastrointestinal cancers
    Meeting Abstract

    Harding, J.; Hofheinz, R.; Elez, E.; Kuboki, Y.; Geng, J.; Schmohl, M.; Dowling, E.; Feng, Y.; Rasco, D.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • KEYNOTE-859: A randomized, double-blind, placebo-controlled phase 3 trial of first-line pembrolizumab plus chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Tabernero, J.; Bang, Y.; Van Cutsem, E.; Fuchs, C.; Janjigian, Y.; Bhagia, P.; Li, K.; Adelberg, D.; Qin, S.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • The impact of real-time clinical alerts on the compliance of anesthesia documentation: A retrospective observational study
    Meeting Abstract

    Tollinche, L. E.; Shi, R.; Hannum, M.; McCormick, P.; Thorne, A.; Tan, K. S.; Yang, G.; Mehta, M.; Yeoh, C.
    Anesthesia and Analgesia (2020)

    Fulltext@MSK | Save
  • Finding meaning in the face of suffering: Meaning-centered psychotherapy and cancer
    Review

    Lichtenthal, W. G.; Roberts, K. E.; Pessin, H.; Applebaum, A.; Breitbart, W.
    Psychiatric Times (2020)

    Fulltext@MSK | Save
  • Polatuzumab vedotin for the treatment of relapsed/refractory diffuse large B-cell lymphoma in transplant-ineligible patients
    Review

    Douglas, M.
    Journal of the Advanced Practitioner in Oncology (2020)

    Fulltext@MSK | Save
  • An evidence-based approach to increasing nurses' publication rates
    Journal Article

    Fischer-Cartlidge, E.
    American Journal of Nursing (2020)

    Fulltext@MSK | Save
  • Inspiring advocacy
    Editorial

    Sheridan, L.
    Rehabilitation Oncology (2020)

    Fulltext@MSK | Save
  • An umbrella approach to test lung cancer therapies
    Editorial

    Drilon, A.; Hellmann, M. D.
    Nature (2020)

    Fulltext@MSK | Save